Boiron
Logotype for Boiron SA

Boiron (BOI) investor relations material

Boiron H1 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Boiron SA
H1 2026 earnings summary17 Sep, 2026

Executive summary

  • Revenue for H1 2026 was €240.3M, down 2.2% year-over-year, with a 0.3% decrease at constant exchange rates, reflecting lower volumes and adverse currency effects, partially offset by favorable pricing.

  • Net income attributable to the group fell 56.8% to €4.9M, and EBITDA dropped 24.2% to €24.0M, mainly due to higher costs and lower sales in France.

  • Operating income dropped 52.1% to €7.5M compared to H1 2025.

  • Operational profitability was impacted by increased costs of goods sold, higher promotional expenses, and a one-off social charge related to changes in French law.

Financial highlights

  • Revenue: €240.3M (-2.2% y/y); at constant FX: -0.3%.

  • Operating income: €7.5M (3.1% margin), down from €15.7M (6.4% margin) in H1 2025.

  • Net income: €4.9M vs. €11.4M in H1 2025.

  • EBITDA: €24.0M vs. €31.7M in H1 2025.

  • Net cash: €50.0M, down from €62.0M a year earlier.

Outlook and guidance

  • Full-year performance will depend on the severity of seasonal illnesses, new product launches, and geopolitical developments.

  • No new risk factors identified; risk mapping unchanged from 2025.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Boiron earnings date

Logotype for Boiron SA
H2 202622 Apr, 2027
Boiron
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

Next Boiron earnings date

Logotype for Boiron SA
H2 202622 Apr, 2027

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Find what matters

AI across all first-party IR material. Live calls, transcripts, slides, filings.
A cited source card from Adobe's CFO alongside a list of forward-looking statements

Trust every finding

50m+ first-party documents. Every output traceable to its source.

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more
An automation set to trigger on the first published earnings document for GE Aerospace

Event-triggered research

Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.
An automation scheduled to run weekly on Mondays at 09:00

Scheduled research

Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more
A live LVMH Q2 2026 earnings call playing in Quartr

Live earnings calls

Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.
A live transcript excerpt from LVMH's Chairman and CEO Bernard Arnault

Live transcripts

Speaker-by-speaker, in real time. Searchable across every live and historical call.

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

Boiron SA is a French company specializing in the production and distribution of homeopathic medicines. The company offers a wide range of homeopathic remedies that are used to treat various conditions, from minor ailments to chronic health issues. Boiron's products are available in different forms, including tablets, liquids, and topical treatments. The company serves healthcare professionals, pharmacies, and consumers, providing accessible homeopathic solutions worldwide. Boiron operates in the pharmaceutical and healthcare sectors, focusing on alternative medicine. The company is headquartered in Messimy, France, and its shares are listed on the Euronext Paris.